Micro-fluidic chip for extracting total nucleic acid of bacteria in human whole blood

A microfluidic chip and nucleic acid technology, applied in the field of molecular biomedicine, can solve the problems of undetectable, missed detection of pathogenic bacteria, single cell wall components, etc., to reduce the possibility of pollution and result deviation, and avoid the possibility of missed detection , The effect of simplifying the operation process

Pending Publication Date: 2018-12-07
SUZHOU TEST DROP DX BIOTECHNOLOGY CO LTD +2
View PDF5 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In addition, it must be pointed out that for different bacteria, the results presented by the same method often vary greatly
There are many published methods for extracting bacterial total nucleic acid, but most methods not only need to use some toxic reagents, but also are time-consuming, complicated, expensive, and the extraction effect is not good.
In addition, many bacteria are difficult to be destroyed and lysed because they are protected by cell walls. For example, Gram-negative bacteria have a relatively single cell wall composition, a fragile structure, and are easily broken; while Gram-positive bacteria have thicker cell walls. The chemical structure is conservative and fixed, the three-dimensional cell wall structure is tightly cross-linked, the cells are difficult to break, and the extraction is difficult
Moreover, the existing methods cannot detect the number of bacteria with extremely low content, resulting in the possibility of missed detection of pathogenic bacteria

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Micro-fluidic chip for extracting total nucleic acid of bacteria in human whole blood

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0041] Specific embodiments of the present invention will be described in detail below in conjunction with the accompanying drawings.

[0042] A microfluidic chip for extracting bacterial total nucleic acid from human whole blood, such as figure 1 As shown, it includes a positioning hole 1 and a main body 2, and the main body 2 includes a sample injection hole 4 located on the sample injection cavity 3, a sample injection cavity 3, one-way valves 5-13, 16, 31, nucleic acid extraction Material 14, nucleic acid extraction cavity 15, PCR reaction cavity 17, buffer I cavity 18, buffer II cavity 19, RNase inhibitor cavity 20, MIX1 cavity 21, DNaseI cavity 22, MIX2 cavity 23. 70% ethanol cavity 24, buffer III cavity 25, MIX3 cavity 26, PCR Master Mix cavity 27, PCR primer cavity 28, PCR reaction probe cavity 29 and buffer V cavity 30;

[0043] The nucleic acid extraction material 14 is located in the nucleic acid extraction cavity 15;

[0044]The nucleic acid extraction cavity 15 ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
radiusaaaaaaaaaa
thicknessaaaaaaaaaa
Login to view more

Abstract

The invention discloses a micro-fluidic chip for extracting total nucleic acid of bacteria in human whole blood. The chip comprises a positioning hole and a main body. The main body comprises a sampling hole formed in a sampling cavity, the sampling cavity, a one-way valve, a nucleic acid extraction material, a nucleic acid extraction cavity, a PCR reaction cavity, a buffer solution I cavity, a buffer solution II cavity, an RNA enzyme inhibitor cavity, an MIX1 cavity, a DNase I cavity, a MIX2 cavity, a 70% ethanol cavity, a buffer solution II cavity, an MIX3 cavity, a PCR Master Mix cavity, aPCR primer cavity, a PCR reaction probe cavity and a buffer solution V cavity. The chip provided by the invention can split the bacteria quickly to release RNA, and is simple and convenient to operate, so that the extraction efficiency is improved greatly; the detection limit is reduced to the lowest, so that the probability of leaked detection is avoided; the operating process of pathogenic bacteria detection is simplified, and the detection error caused by manual operations is reduced.

Description

technical field [0001] The invention relates to the technical field of molecular biomedicine, in particular to a microfluidic chip for extracting bacterial total nucleic acid from human whole blood. Background technique [0002] Bacterial infection is one of the most common diseases in the world, which can easily lead to a variety of diseases. The main clinical manifestations are: sudden chills, high fever, tachycardia, shortness of breath, rash, hepatosplenomegaly and mental and mental changes And a series of serious clinical symptoms, which are very harmful and can easily lead to death. Therefore, rapid determination of bacterial types in human whole blood has great academic research and clinical application value for understanding the diversity of bacteria in whole blood, guiding the selection and use of antibiotics, and killing toxic bacteria. In order to obtain high-quality total nucleic acids from different bacteria, pre-sample processing, extraction methods and selec...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12M1/00C12N15/10C12Q1/686
CPCC12M23/16C12N15/1003C12Q1/686
Inventor 张惠丹赵洪玉程玉苗
Owner SUZHOU TEST DROP DX BIOTECHNOLOGY CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products